Sulfation of buprenorphine, pentazocine, and naloxone by Human Cytosolic Sulfotransferases

Drug Metabolism Letters

Volumn 6, Issue 2, 2012, Pages 109-115

  Kurogi, Katsuhisa ^a   Chen, Mei ^a   Lee, Yoonjung ^a   Shi, Bo ^a   Yan, Teng ^a   Liu, Ming Yih ^b   Sakakibara, Yoichi ^c   Suiko, Masahito ^c   Liu, Ming Cheh ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NATIONAL SYNCHROTRON RADIATION RESEARCH CENTER   (Taiwan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Buprenorphine; Cytosolic sulfotransferase; Naloxone; Opioids; Pentazocine; Sulfation

Indexed keywords

BUPRENORPHINE; NALOXONE; PENTAZOCINE; SULFOTRANSFERASE; SULT1A3; SULT2A1; UNCLASSIFIED DRUG;

ARTICLE; CYTOSOL; DRUG ACTIVITY; DRUG PROTEIN BINDING; ENZYMATIC ASSAY; ENZYME SUBSTRATE; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IC 50; KIDNEY; LIVER; LUNG; PRIORITY JOURNAL; SMALL INTESTINE; SULFATION;

ANALGESICS, OPIOID; BUPRENORPHINE; CARCINOMA, HEPATOCELLULAR; CYTOSOL; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NALOXONE; NARCOTIC ANTAGONISTS; PENTAZOCINE; SULFATES; SULFOTRANSFERASES;

EID: 84872575044     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231212804096673     Document Type: Article

References (51)

1. Pasternak, G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol., 1993, 16, 1-18.
2. Inturrisi, C.E. Clinical pharmacology of opioids for pain. Clin. J. Pain, 2002, 18, S3-13.
3. Ballantyne, J.C.; Shin, N.S. Efficacy of opioids for chronic pain: a review of the evidence. Clin. J. Pain, 2008, 24, 469-478.
4. Krenzischek, D.A.; Dunwoody, C.J.; Polomano, R.C.; Rathmell, J.P. Pharmacotherapy for acute pain: implications for practice. J. Perianesth. Nurs., 2008, 23, S28-42.
5. Johnson, R.E.; Fudala, P.J.; Payne, R. Buprenorphine: considerations for pain management. J. Pain Symptom Manage., 2005, 29, 297-326.
6. Robinson, S.E. Buprenorphine-containing treatments: place in the management of opioid addiction. CNS Drugs, 2006, 20, 697-712.
7. Orman, J.S.; Keating, G.M. Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence. Drugs, 2009, 69, 577-607.
8. Chamberlain, J.M.; Klein, B.L. A comprehensive review of naloxone for the emergency physician. Am. J. Emerg. Med., 1994, 12, 650-660.
9. Challoner, K.R.; McCarron, M.M.; Newton, E.J. Pentazocine (Talwin) intoxication: report of 57 cases. J. Emerg. Med., 1990, 8, 67-74.
10. Fudala, P.J.; Johnson, R.E. Development of opioid formulations with limited diversion and abuse potential. Drug Alcohol Depend., 2006, 1, S40-47.
11. Harris, D.S.; Jones, R.T.; Welm, S.; Upton, R.A.; Lin, E.; Mendelson, J. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug Alcohol Depend., 2000, 61, 85-94.
12. Iribarne, C.; Picart, D.; Dréano, Y.; Bail, J.P.; Berthou, F. Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes. Life Sci., 1997, 60, 1953-1964.
13. Rouguieg, K.; Picard, N.; Sauvage, F.L.; Gaulier, J.M.; Marquet, P. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes. Drug Metab. Dispos., 2010, 38, 40-45.
14. Pittman, K.A.; Rosi, D.; Cherniak, R.; Merola, A.J.; Conway, W. D. Metabolism in vitro and in vivo of pentazocine. Biochem Pharmacol., 1969, 18, 1673-1678.
15. Berkowitz, B. Influence of plasma levels and metabolism on pharmacological activity: pentazocine. Ann. N. Y. Acad. Sci., 1971, 179, 269-281.
16. Chiang, C.N.; Hawks, R.L. Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend., 2003, 70, S39-47.
17. Mulder, G.M.; Jakoby, W.B. Sulfation in conjugation reactions. In: Drug Metabolism; Mulder, G.J. Ed., Taylor and Francis, London, 1990, pp.107-161.
18. Falany, C.N.; Roth, J.A. Properties of human cytosolic sulfotransferases involved in drug metabolism. In: Human Drug Metabolism; from Molecular Biology to Man; Jeffery, E.H. Ed.; CRC Press, Boca Raton, 1994, pp. 101-115.
19. Weinshilboum, R.M.; Otterness, D.M. Sulfotransferase enzymes. In: Conjugation-Deconjugation reactions in Drug Metabolism and Toxicity; Kaufman, F.C. Ed.; Springer-Verlag, Berlin, 1994, pp. 45-78.
20. Lipmann, F. Biological sulfate activation and transfer. Science, 1958, 128, 575-580.
21. Veronese, M.E.; Burgess, W.; Zhu, X.; McManus, M.E. Functional characterization of two human sulphotransferase cDNAs that encode monoamine-and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies. Biochem. J., 1994, 302, 497-502.
22. Wilborn, T.W.; Comer, K.A.; Dooley, T.P.; Reardon, I.M.; Heinrikson, R.L.; Falany C.N. Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Mol. Pharmacol., 1993, 43, 70-77.
23. Wood, T.C.; Aksoy, I.A.; Aksoy, S.; Weinshilboum, R.M. Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. Biochem. Biophys. Res. Commun., 1994, 198, 1119-1127.
24. Wang, J.; Falany, J.L.; Falany, C.N. Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver. Mol. Pharmacol., 1998, 53, 274-282.
25. Her, C.; Kaur, G.P.; Athwal, R.S.; Weinshilboum, R.M. Human sulfotransferase SULT1C1: cDNA cloning, tissue-specific expression, and chromosomal localization. Genomics, 1997, 41, 467-470.
26. Sakakibara, Y.; Yanagisawa, K.; Katafuchi, J.; Ringer, D.P.; Takami, Y.; Nakayama, T.; Suiko, M.; Liu. M.-C. Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene. J. Biol. Chem., 1998, 273, 33929-33935.
27. Aksoy, I.A.; Wood, T.C.; Weinshilboum, R.M. Human liver estrogen sulfotransferase: identification by cDNA cloning and expression. Biochem. Biophys. Res. Commun., 1994, 200, 1621-1629.
28. Falany, C.N.; Vazquez, M.E.; Kalb, J.M. Purification and characterization of human liver dehydroepiandrosterone sulphotransferase. Biochem. J., 1989, 260, 641-646.
29. Otterness, D.M.; Wieben, E.D.; Wood, T.C.; Watson, W.G.; Madden, B.J.; McCormick, D.J., Weinshilboum, R.M. Human liver dehydroepiandrosterone sulfotransferase: molecular cloning and expression of cDNA. Mol. Pharmacol., 1992, 41, 865-872.
30. Fuda, H.; Lee, Y.C.; Shimizu, C.; Javitt, N.B.; Strott C.A. Mutational analysis of human hydroxysteroid sulfotransferase SULT2B1 isoforms reveals that exon 1B of the SULT2B1 gene produces cholesterol sulfotransferase, whereas exon 1A yields pregnenolone sulfotransferase. J. Biol. Chem., 2002, 277, 36161-36166.
31. Her, C.; Wood, T.C.; Eichler, E.E.; Mohrenweiser, H.W.; Ramagli, L.S.; Siciliano, M.J.; Weinshilboum, R.M. Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene. Genomics, 1998, 53, 284-295.
32. Falany, C.N.; Xie, X.; Wang, J.; Ferrer, J.; Falany, J.L. Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain. Biochem. J., 2000, 346, 857-864.
33. Sakakibara, Y.; Suiko, M.; Pai, T.G.; Nakayama, T.; Takami, Y.; Katafuchi, J.; Liu, M.-C. Highly conserved mouse and human brain sulfotransferases: molecular cloning, expression, and functional characterization. Gene, 2002, 285, 39-47.
34. Falany, C.N. Enzymology of human cytosolic sulfotransferases. FASEB J., 1997, 11, 206-216.
35. Sugahara, T.; Pai, T.G.; Suiko, M.; Sakakibara, Y.; Liu, M.-C. Differential roles of human monoamine (M)-form and simple phenol (P)-form phenol sulfotransferases in drug metabolism. J. Biochem., 2003, 133, 259-262.
36. Meloche, C.A.; Sharma, V.; Swedmark, S.; Andersson, P.; Falany, C.N. Sulfation of budesonide by human cytosolic sulfotransferase, dehydroepiandrosterone-sulfotransferase (DHEA-ST). Drug Metab. Dispos., 2002, 30, 582-585.
37. Falany, J.L.; Macrina, N.; Falany, C.N. Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases. J. Steroid Biochem. Mol. Biol., 2004, 88, 383-391.
38. Suiko, M.; Sakakibara, Y.; Liu, M.-C. Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases. Biochem. Biophys. Res. Commun., 2000, 267, 80-84.
39. Pai, T.G.; Sugahara, T.; Suiko, M.; Sakakibara, Y.; Xu, F.; Liu, M.-C. Differential xenoestrogen-sulfating activities of the human cytosolic sulfotransferases: molecular cloning, expression, and purification of human SULT2B1a and SULT2B1b sulfotransferases. Biochim. Biophys. Acta., 2002, 1573, 165-170.
40. Sakakibara, Y.; Takami, Y.; Nakayama, T.; Suiko, M.; Liu, M.-C. Localization and functional analysis of the substrate specificity/ catalytic domains of human M-form and P-form phenol sulfotrans-ferases. J. Biol. Chem., 1998, 273, 6242-6247.
41. Yanagisawa, K.; Sakakibara, Y.; Suiko, M.; Takami, Y.; Nakayama, T.; Nakajima, H.; Takayanagi, K.; Natori, Y.; Liu, M.-C. cDNA cloning, expression, and characterization of the human bifunctional ATP sulfurylase/adenosine 5'-phosphosulfate kinase enzyme. Biosci. Biotechnol. Biochem., 1998, 62, 1037-1040.
42. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227, 680-685.
43. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 1976, 72, 248-254.
44. Chen, X.; Baker, S.M.; Chen, G. Methotrexate induction of human sulfotransferases in HepG2 and Caco-2 cells. J. Appl. Toxicol., 2005, 25, 354-360.
45. Westerink, W.M.; Schoonen, W.G. Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. In Vitro, 2007, 21, 1592-1602.
46. Miyano, J.; Yamamoto, S.; Hanioka, N.; Narimatsu, S.; Ishikawa, T.; Ogura, K.; Watabe, T.; Nishimura, M.; Ueda, N.; Naito, S. Involvement of SULT1A3 in elevated sulfation of 4-hydroxypropranolol in Hep G2 cells pretreated with beta-naphthoflavone. Biochem. Pharmacol., 2005, 69, 941-950.
47. Dooley, T.P.; Haldeman-Cahill, R.; Joiner, J.; Wilborn, T.W. Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem. Biophys. Res. Commun., 2000, 277, 236-245.
48. Riches, Z.; Stanley, E.L.; Bloomer, J.C.; Coughtrie, M.W. Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie". Drug Metab. Dispos., 2009, 37, 2255-2261.
49. Chiang, C.N.; Hawks, R.L. Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend., 2003, 70, S39-47.
50. Goldstein, G. Pentazocine. Drug Alcohol Depend., 1985, 14, 313-323.
51. Misra, A.L.; Pontani, R.B.; Vadlamani, N.L.; Mulé, S.J. Physiological disposition and biotransformation of [allyl-1', 3'-14C] naloxone in the rat and some comparative observations on nalorphine. J. Pharmacol. Exp. Ther., 1976, 196, 257-268.